C08G67/00

Ring-opening polymerizations using a flow reactor

Techniques regarding the synthesis of one or more polymers through one or more ring-opening polymerizations conducted within a flow reactor and facilitated by one or more anionic catalysts are provided. For example, one or more embodiments can comprise a method, which can comprise polymerizing, via a ring-opening polymerization within a flow reactor, a cyclic monomer in the presence of one or more anionic organocatalysts.

Ring-opening polymerizations using a flow reactor

Techniques regarding the synthesis of one or more polymers through one or more ring-opening polymerizations conducted within a flow reactor and facilitated by one or more anionic catalysts are provided. For example, one or more embodiments can comprise a method, which can comprise polymerizing, via a ring-opening polymerization within a flow reactor, a cyclic monomer in the presence of one or more anionic organocatalysts.

ELECTRODE HAVING HIGH OXYGEN PERMEABILITY FOR FUEL CELL AND MEMBRANE-ELECTRODE ASSEMBLY COMPRISING SAME
20220021006 · 2022-01-20 ·

Disclosed are an electrode for a fuel cell a membrane-electrode assembly including the same, and a method of preparing the same. The electrode may include catalyst particles; and a binder in which the catalyst particles are dispersed. In particular, the binder may include an ionomer having proton conductivity and a polymer of intrinsic microporosity (PIM) in order to implement high oxygen permeability.

ELECTRODE HAVING HIGH OXYGEN PERMEABILITY FOR FUEL CELL AND MEMBRANE-ELECTRODE ASSEMBLY COMPRISING SAME
20220021006 · 2022-01-20 ·

Disclosed are an electrode for a fuel cell a membrane-electrode assembly including the same, and a method of preparing the same. The electrode may include catalyst particles; and a binder in which the catalyst particles are dispersed. In particular, the binder may include an ionomer having proton conductivity and a polymer of intrinsic microporosity (PIM) in order to implement high oxygen permeability.

Polymeric biomaterials derived from phenolic monomers and their medical uses

The present invention provides new classes of phenol compounds, including those derived from tyrosol and analogues, useful as monomers for preparation of biocompatible polymers, and biocompatible polymers prepared from these monomeric phenol compounds, including novel biodegradable and/or bioresorbable polymers. These biocompatible polymers or polymer compositions with enhanced bioresorbabilty and processibility are useful in a variety of medical applications, such as in medical devices and controlled-release therapeutic formulations. The invention also provides methods for preparing these monomeric phenol compounds and biocompatible polymers.

Polymeric biomaterials derived from phenolic monomers and their medical uses

The present invention provides new classes of phenol compounds, including those derived from tyrosol and analogues, useful as monomers for preparation of biocompatible polymers, and biocompatible polymers prepared from these monomeric phenol compounds, including novel biodegradable and/or bioresorbable polymers. These biocompatible polymers or polymer compositions with enhanced bioresorbabilty and processibility are useful in a variety of medical applications, such as in medical devices and controlled-release therapeutic formulations. The invention also provides methods for preparing these monomeric phenol compounds and biocompatible polymers.

RADIOPAQUE POLYMERS

A hydrophilic polymer comprising pendent groups of the formula I: Wherein: W is independently selected from —OH, —COOH, —SO.sub.3H, —OPO.sub.3H, —O—(C.sub.1-4alkyl), —O—(C.sub.1-4alkyl)OH, —O—(C.sub.1-4alkyl)R.sup.2, —O—(C.sub.2H.sub.5O).sub.qR.sup.1—(C═O)—O—C.sub.1-4alkyl and —O—(C═O)C.sub.1-4alkyl; or a group —BZ; wherein —OH, COOH, O—PO.sub.3H and SO.sub.3H maybe in the form of a pharmaceutically acceptable salt; wherein: B is a bond, or a straight branched alkanediyl, oxyalkylene, alkylene oxaalkylene, or alkylene (oligooxalkylene) group, optionally containing one or more fluorine substituents; and Z is an ammonium, phosphonium, or sulphonium phosphate or phosphonate ester zwitterionic group; X is either a bond or a linking group having 1 to 8 carbons and optionally 1 to 4 heteroatoms selected from O, N and S; G is a coupling group through which the group of the formula I is coupled to the polymer and is selected from ether, ester, amide, carbonate, carbamate, 1,3 dioxolone, and 1,3 dioxane; R.sup.1 is H or C.sub.1-4 alkyl; R.sup.2 is —COOH, —SO.sub.3H, or —OPO.sub.3H.sub.2 q is an integer from to 4; n is an integer from 1 to 4; p is an integer from 1 to 3; and n+p is from 2 to 5; and wherein —COOH, —OPO.sub.3H.sub.2 and —SO.sub.3H as well as phenolic —OH maybe in the form of a pharmaceutically acceptable salt.

RADIOPAQUE POLYMERS

A hydrophilic polymer comprising pendent groups of the formula I: Wherein: W is independently selected from —OH, —COOH, —SO.sub.3H, —OPO.sub.3H, —O—(C.sub.1-4alkyl), —O—(C.sub.1-4alkyl)OH, —O—(C.sub.1-4alkyl)R.sup.2, —O—(C.sub.2H.sub.5O).sub.qR.sup.1—(C═O)—O—C.sub.1-4alkyl and —O—(C═O)C.sub.1-4alkyl; or a group —BZ; wherein —OH, COOH, O—PO.sub.3H and SO.sub.3H maybe in the form of a pharmaceutically acceptable salt; wherein: B is a bond, or a straight branched alkanediyl, oxyalkylene, alkylene oxaalkylene, or alkylene (oligooxalkylene) group, optionally containing one or more fluorine substituents; and Z is an ammonium, phosphonium, or sulphonium phosphate or phosphonate ester zwitterionic group; X is either a bond or a linking group having 1 to 8 carbons and optionally 1 to 4 heteroatoms selected from O, N and S; G is a coupling group through which the group of the formula I is coupled to the polymer and is selected from ether, ester, amide, carbonate, carbamate, 1,3 dioxolone, and 1,3 dioxane; R.sup.1 is H or C.sub.1-4 alkyl; R.sup.2 is —COOH, —SO.sub.3H, or —OPO.sub.3H.sub.2 q is an integer from to 4; n is an integer from 1 to 4; p is an integer from 1 to 3; and n+p is from 2 to 5; and wherein —COOH, —OPO.sub.3H.sub.2 and —SO.sub.3H as well as phenolic —OH maybe in the form of a pharmaceutically acceptable salt.

POLYARYLENE ETHER KETONE RESIN AND PRODUCTION METHOD THEREFOR, AND MOLDED ARTICLE

A polyarylene ether ketone resin has a repeating unit (1-1) represented by general formula (1-1) below and a repeating unit (2-1) represented by general formula (2-1) below. In the formulae, R is a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, Ar1 and Ar2 are each a divalent organic group (3-1) represented by general formula (3-1) below, and n is 0 or 1.

##STR00001##

POLYARYLENE ETHER KETONE RESIN AND PRODUCTION METHOD THEREFOR, AND MOLDED ARTICLE

A polyarylene ether ketone resin has a repeating unit (1-1) represented by general formula (1-1) below and a repeating unit (2-1) represented by general formula (2-1) below. In the formulae, R is a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, Ar1 and Ar2 are each a divalent organic group (3-1) represented by general formula (3-1) below, and n is 0 or 1.

##STR00001##